Brandinium

Trademark search for:

PREVALIN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-06-17 — Application filed
  • 2016-10-01 — Sn assigned for sect 66a subseq desig from ib
  • 2016-10-12 — Application filed
  • 2016-10-13 — Application filed
  • 2016-10-13 — Assigned to examiner
  • 2016-10-14 — Final disposition recorded
  • 2016-10-15 — Office action issued
  • 2016-10-18 — Application filed
  • 2016-11-09 — Office action issued
  • 2016-11-09 — Office action issued
  • 2016-12-09 — Office action issued
  • 2017-01-13 — Office action issued
  • 2017-02-02 — Assigned to lie
  • 2017-02-10 — Correction transaction received from ib
  • 2017-02-15 — Teas/email correspondence entered
  • 2017-02-15 — Correspondence received in law office
  • 2017-03-06 — Approved for pub - principal register
  • 2017-03-07 — Law office publication review completed
  • 2017-03-21 — Correction from ib entered - no review required
  • 2017-03-22 — Notice of publication
  • 2017-03-22 — Notice of start of opposition period created, to be sent to ib
  • 2017-03-22 — Notification of possible opposition sent to ib
  • 2017-04-08 — Notification processed by ib
  • 2017-04-11 — Published for opposition
  • 2017-06-27 — Registered-principal register
  • 2017-09-27 — Final disposition recorded
  • 2017-09-29 — Generic madrid transaction created
  • 2017-09-29 — Generic madrid transaction sent to ib
  • 2017-11-10 — Final disposition recorded
  • 2022-03-12 — New representative at ib received
  • 2022-04-14 — International registration renewed
  • 2024-01-12 — Cancelled section 71
  • 2024-01-12 — Final status recorded
  • 2024-05-19 — Change of name/address rec'd from ib
  • 2024-05-19 — New representative at ib received
  • 2024-09-13 — Total invalidation of reg ext protection created
  • 2024-09-14 — Invalidation processed
  • 2024-09-14 — Total invalidation of reg ext protection sent to ib
  • 2024-10-07 — Total invalidation processed by the ib
  • 2025-01-03 — New representative at ib received
  • 2025-03-20 — Change of owner received from ib

Owner Information

Perrigo Pharma International DAC
IE
Omega Pharma Innovation & Development NV
BE
Omega Pharma Innovation & Development NV
BE
Omega Pharma Innovation & Development NV
BE
Omega Pharma Innovation & Development NV
BE

Correspondent

Omega Pharma IP
Venecoweg 26
B-9810 NAZARETH,
BELGIUM

Filing Details

Filing Date:
2016-06-17
Status Date:
2024-01-12
Category:
Pharmaceuticals
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.